In type 2 diabetes rat models, where bone mass is often reduced, contrary to humans, where bone mass is often normal or increased, liraglutide administration in the range of ~ 110160 nmol/kg/day resulted in increased trabecular BMD and restoration of trabecular microarchitecture parameters in the appendicular and axial skeleton [63,64,65,66,67]
Perfect for weight management goals
Patients should also inform their healthcare provider if gastrointestinal side effects prevent them from taking other essential medications or if they experience significant weight loss beyond their target, as dose adjustment may be necessary
Most people use a low carb sauce from Rao's
general overall need for cellular uptake-ability, non-binding properties to assure free transit, etc
A healthcare provider will review all your medications